ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Akari Therapeutics (AKTX)

Technical Analysis Report for NASDAQ stock AKTX Akari Therapeutics. Dated: 16 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock AKTX Akari Therapeutics then click here. or read Experts views on Akari Therapeutics or Forecast & share price targets of Akari Therapeutics

Akari Therapeutics Opened at 0.27 and Closed at: 0.28, which is 3.57% of previous session's close. It moved within a range of 0.27 and 0.31
The session was a Bullish session with an average volume of 307963, which is -29.95% of previous session's volumes.

  • Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.

A Golden cross was found 3 days back on short term averages

Support for tomorrow is 0.28 and resistance for tomorrow is 0.32
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 0.26, 0.25 resistance for tomorrow's hourly charts is 0.3, 0.33

10 Day SMA for Akari Therapeutics (AKTX) is 0.28 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Akari Therapeutics (AKTX) is 0.27 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Akari Therapeutics (AKTX) is 0.38 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 0.61 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Akari Therapeutics is 0.89 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Akari Therapeutics is at 0.27 and 200 DMA is at 0.89, while 50 DMA and 100 DMA are at 0.38 and 0.61 respectively

Akari Therapeutics (AKTX) moving average of 20 SMA is at 0.27 and 20 EMA is at 0.32

Date Closing Price 20 SMA 20 EMA
16 Fri Jan 0.28 0.27 0.32
15 Thu Jan 0.27 0.27 0.32
14 Wed Jan 0.27 0.27 0.32
13 Tue Jan 0.28 0.28 0.32
12 Mon Jan 0.28 0.28 0.32
09 Fri Jan 0.28 0.29 0.32

Akari Therapeutics (AKTX) moving average of 50 SMA is at 0.38 and 50 EMA is at 0.39

Date Closing Price 50 SMA 50 EMA
16 Fri Jan 0.28 0.38 0.39
15 Thu Jan 0.27 0.39 0.39
14 Wed Jan 0.27 0.4 0.39
13 Tue Jan 0.28 0.41 0.4
12 Mon Jan 0.28 0.42 0.4
09 Fri Jan 0.28 0.43 0.41

Akari Therapeutics (AKTX) moving average of 100 SMA is at 0.61 and 100 EMA is at 0.52

Date Closing Price 100 SMA 100 EMA
16 Fri Jan 0.28 0.61 0.52
15 Thu Jan 0.27 0.62 0.52
14 Wed Jan 0.27 0.62 0.52
13 Tue Jan 0.28 0.63 0.53
12 Mon Jan 0.28 0.64 0.53
09 Fri Jan 0.28 0.64 0.53

Akari Therapeutics (AKTX) moving average of 200 SMA is at 0.89 and 200 EMA is at 0.77

Date Closing Price 200 SMA 200 EMA
16 Fri Jan 0.28 0.89 0.77
15 Thu Jan 0.27 0.9 0.77
14 Wed Jan 0.27 0.9 0.77
13 Tue Jan 0.28 0.91 0.78
12 Mon Jan 0.28 0.91 0.78
09 Fri Jan 0.28 0.92 0.78
Related Company CMP Open More...
Arsanis Inc 0.47 0.45 Tips NEWS Tomorrow Forecast Targets ExpertsView Analysis Munafa AI prediction
Corcept Therapeutics 34.73 35.39 Tips NEWS Tomorrow Forecast Targets ExpertsView Analysis Munafa AI prediction
Xtl Biopharmaceuticals 0.98 0.97 Tips NEWS Tomorrow Forecast Targets ExpertsView Analysis Munafa AI prediction
Arrowhead Pharmaceuticals 63.84 66.45 Tips NEWS Tomorrow Forecast Targets ExpertsView Analysis Munafa AI prediction
Lemaitre Vascular 88.27 86.29 Tips NEWS Tomorrow Forecast Targets ExpertsView Analysis Munafa AI prediction
Masimo Corporation 142.05 139.35 Tips NEWS Tomorrow Forecast Targets ExpertsView Analysis Munafa AI prediction

Xtl Biopharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Xtl Biopharmaceuticals, about 8.99% more returns!

Akari Therapeutics has performed better than Masimo Corporation in short term. Holding Akari Therapeutics could be a better choice for now!

Akari Therapeutics has performed better than Lemaitre Vascular in short term. Holding Akari Therapeutics could be a better choice for now!

Akari Therapeutics has performed better than Arrowhead Pharmaceuticals in short term. Holding Akari Therapeutics could be a better choice for now!

Akari Therapeutics has performed better than Arsanis Inc in short term. Holding Akari Therapeutics could be a better choice for now!

Akari Therapeutics has performed better than Corcept Therapeutics in short term. Holding Akari Therapeutics could be a better choice for now!

Akari Therapeutics Technical analysis of indicators

Price action analysis of Akari Therapeutics (AKTX) based on a short term time period is neutral. A longer time frame might give a better analysis.

ADX buy sell signal for Akari Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Akari Therapeutics in short term but the buy signal is initial and weak.

Akari Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

CCI has generated a buy signal for Akari Therapeutics in short term and BUY signal is strong.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Akari Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 0.28 and Akari Therapeutics AKTX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Akari Therapeutics AKTX stock. Volume based technical analysis of Akari Therapeutics AKTX stock is negative.

Akari Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Akari Therapeutics indicators chart

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock AKTX Akari Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And AKTX Experts View which covers a lot of information including buying and selling signals

AKTX future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Akari Therapeutics or View Candle Stick Charts here

Chart Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics [

Videos related to: Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics [

 

Back to top